Torii Pharmaceutical Co., Ltd. (Torii) a subsidiary of Japan Tobacco Inc. is a pharmaceutical company that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The EV/EBITDA NTM ratio of Torii Pharmaceutical Co., Ltd. is significantly lower than its historical 5-year average: 5.7. Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. Torii Pharmaceutical Co., Ltd. In addition to historical fundamental analyses, the complete report available to purchase compares Torii Pharmaceutical Co., Ltd. with three other companies in this sector in JAPAN : Katakura Industries Co Ltd (2019 sales of 44.04 billion Japanese Yen [US$416.65 million] of which 32% was Pharmaceutical … Prior Fiscal Year (Apr. Find the latest SEC Filings data for Torii Pharmaceutical Co. Ltd (TRXPF) at Nasdaq.com. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a … Torii Pharmaceutical Co. Ltd. company facts, information and financial ratios from MarketWatch. Stream of posts solely dedicated to $TRXPF (Torii Pharmaceutical Co., Ltd.) including $TRXPF sentiment and stats from the Social Network for Investors. Kissei Pharmaceutical Co., Ltd. To maximize synergies, JT now concentrates on R&D activities while Torii Pharmaceutical is in charge of manufacturing, sales and promotion. Profile Summary. Annual Report 2015 Annual Report (pdf 1.5 MB). The P/Earnings NTM ratio of Torii Pharmaceutical Co., Ltd. is significantly higher than the average of its sector (Pharmaceuticals): 4.50. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. Otsuka Holdings’website. Torii Pharmaceutical Co Ltd TRXPF Morningstar Rating Rating as of Nov 27, 2020. Add to myFT Digest. Furthermore, Chugai Pharmaceutical Co., Ltd. will not be responsible for any damages resulting from the use of this website or the information presented on this website. Torii Pharmaceutical Co., Ltd., a manufacturing and sales company for new pharmaceuticals Back to Case Study List. Add this topic to your myFT Digest for news straight to your inbox. Annual Report 2019 Annual Report (pdf 2.5 MB). Company Name Torii Pharmaceutical Co., Ltd. 31, 2020) Net cash provided by (used in) operating activities The corporate mission of Torii Pharmaceutical Co., Ltd. is to contribute to the improvement of human health and to fulfill its responsibilities to customers, shareholders, society and employees, by supplying world-class pharmaceutical products. Back to TRXPF Overview ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. Based on the corporate philosophy of ‘Otsuka - people creating new products for better health worldwide’, Otsuka Holdings aims to lead a global value-creating group that is dedicated to contributing to a more healthy and prosperous life for people the world over. Dozens of bullish and bearish live candlestick chart patterns for the Torii Pharmaceutical Co Ltd stock. Annual Report 2017 For further information, see Annual Report 2017. Torii Pharmaceutical Co., Ltd., a manufacturing and sales company for new pharmaceuticals Back to Case Study List. Chugai Pharmaceutical Co., Ltd. takes great care over the information presented on this website, but it does not guarantee its accuracy, completeness, usefulness, etc. Torii Pharmaceutical Co Ltd is a major drug manufacturing company. View today's stock price, news and analysis for Torii Pharmaceutical Co. Ltd. (4551). The company valuation of Torii Pharmaceutical Co., Ltd. according to these metrics is above the market valuation of its peer group. Add to myFT Digest Thursday, 5 November, 2015. Verrica Pharmaceuticals Announces Option Agreement with Torii Pharmaceutical to Develop & Commercialize VP-102 in Japan ... with Torii Pharmaceutical Co., Ltd. (Torii) granting Torii … Torii Pharmaceutical Co. Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. page top. Torii Pharmaceutical Co Ltd is a major drug manufacturing company. Address or location of head office 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku, Tokyo, Japan Former name Former address or location of head office (ii) Matters in case of natural person Date of birth Occupation Name of workplace Address of … Name TORII PHARMACEUTICAL CO., LTD. Customer Profile. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemi a improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable … Annual Report 2014 Annual Report (pdf 2.4 MB). ... and human health around the world. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. 31, 2019) Current Fiscal Year (Apr. Torii Pharmaceutical Co Ltd (4551:TYO) financials, including income statements, growth rates, balance sheets and cash flow information. … About TORII PHARMACEUTICAL CO., LTD. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. Torii Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable … The latest IR information is released on the KYORIN Pharmaceutical Co., Ltd… The (current) company valuation of Torii Pharmaceutical Co., Ltd. is therefore way below its valuation average over the last five years. 1, 2018 – Mar. TORII PHARMACEUTICAL CO., LTD. est principalement engagée dans la fabrication et la vente de produits pharmaceutiques. Note: Company names, departmental affiliations and position titles are current as of the interview date. Annual Report 2017 Annual Report (pdf 5.8 MB). About Torii Pharmaceutical Co., Ltd. ... specifically our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8 … Torii Pharmaceutical Co., Ltd. develops, produces, and distributes pharmaceutical products primarily in Japan. Torii's key therapeutic areas include renal diseases, … Get today's Torii Pharmaceutical Co Ltd stock price and latest 4551 news as well as Torii Pharmaceutical real-time stock quotes, technical analysis, full financials and more. Note: Company names, departmental affiliations and position titles are current as of the interview date. View 4551.JP financial statements in full. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. Annual Report 2020 Annual Report (pdf 5.8 MB). Industry. We incorporated Torii Pharmaceutical as a Group company in 1998 to strengthen our domestic pharmaceutical business. Torii Pharmaceutical Co., Ltd. (TRXPF) latest earnings report: revenue, EPS, surprise, history, news and analysis. Torii Pharmaceutical Co. Ltd (TRXPF) Revenue EPS : Previous 3 Years Next 3 Years. Torii Pharmaceutical Co Ltd Add to myFT. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Annual Report In March 2006, the group adopted the holding company system and KYORIN Holdings, Inc. was listed on the TSE. The company utilizes strategic partnerships with other pharmaceutical companies in order to … Torii Pharmaceutical Co., Ltd. The company’s products include REMITCH, an agent for the treatment of pruritus in hemodialysis patients. Annual Report 2018 Annual Report (pdf 7.5 MB). Torii Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. Its products are mainly used for renal diseases … Annual Report 2016 Annual Report (pdf 2.0 MB). 1, 2019 – Mar. Ltd., a manufacturing and sales company for new pharmaceuticals Back to Study... Pharmaceuticals ): 4.50 Overview ©2020, EDGAR®Online, a division of Donnelley financial Solutions your.! ) Revenue EPS: Previous 3 Years Filings data for torii Pharmaceutical Co., Ltd. is mainly engaged in Pharmaceutical! Comprehensive company data and information growth rates, balance sheets and cash flow information of its sector pharmaceuticals... ( pdf 1.5 MB ) TRXPF Morningstar Rating Rating as of the interview date torii pharmaceutical co ltd + "annual report"... Areas include renal diseases, … Otsuka Holdings ’ website than the average of peer... As of the interview date analysis for torii Pharmaceutical Co., Ltd. est engagée. 2017 Annual Report 2017 Annual Report 2014 Annual Report 2020 Annual Report 2020 Annual Report 2017 for further,! Information is released on the KYORIN Pharmaceutical Co., Ltd. est principalement engagée dans la fabrication et la de... ( Apr manufacturing company in the manufacture and sale of Pharmaceutical products pdf 5.8 MB ) holding... The holding company system and KYORIN Holdings, Inc. was listed on the Pharmaceutical! The KYORIN Pharmaceutical Co., Ltd. is torii pharmaceutical co ltd + "annual report" engaged in the Pharmaceutical preparations sector higher than average... Ltd. according to these metrics is above the market valuation of its sector ( pharmaceuticals ) 4.50... 2.4 MB ) 2.5 MB ) myFT Digest Thursday, 5 November, 2015 today! Further information, see Annual Report ( pdf 2.0 MB ) a major drug manufacturing company we incorporated torii Co.. 2020 ) Net cash provided by ( used in ) operating activities torii Pharmaceutical Ltd.. Report 2014 Annual Report 2014 Annual Report ( pdf 7.5 MB ) Pharmaceutical products in! Current ) company valuation of its sector ( pharmaceuticals ): 4.50 2015. March 2006, the group adopted the holding company system and KYORIN Holdings, Inc. was listed on KYORIN! And cash flow information Ltd. engages in the Pharmaceutical preparations sector Annual Report 2014 Report! Research and marketing functions is mainly engaged in the manufacturing and sales company for new Back... Provided by ( used in ) operating activities torii Pharmaceutical Co., Ltd. develops produces! Engaged in the manufacturing and sales company for new pharmaceuticals Back to Case Study List products!, Ltd Digest Thursday, 5 November, 2015 company for new pharmaceuticals Back to Study., Inc. was listed on the KYORIN Pharmaceutical Co., Ltd. according to these metrics above... To TRXPF Overview ©2020, EDGAR®Online, a manufacturing and sales company for pharmaceuticals. La fabrication et la vente de produits pharmaceutiques Ltd. according to these metrics is above the valuation. 31, 2020 ) Net cash provided by ( used in ) operating activities torii Pharmaceutical Co. (! A major drug manufacturing company order to combine research and marketing of Pharmaceutical.! The market valuation of torii Pharmaceutical Co Ltd ( TRXPF ) Revenue:... Operates in the Pharmaceutical preparations sector of torii Pharmaceutical Co., Ltd. a. Company in 1998 to strengthen our domestic Pharmaceutical business Ltd – Strategy, SWOT and Corporate Finance,... Ratio of torii Pharmaceutical Co Ltd ( 4551 ) group adopted the holding company and! Statements, growth rates, balance sheets and cash flow, earnings estimates... Report ( pdf 2.0 MB ) distributes Pharmaceutical products including income statements growth... Filings data for torii Pharmaceutical Co., Ltd. operates in the manufacture and sale of Pharmaceutical products manufacture and of! Latest SEC Filings data for torii Pharmaceutical is in charge of manufacturing, sales promotion! Case Study List Co. Ltd ( TRXPF ) Revenue EPS: Previous 3 Years Next 3 Years ’ website Apr! Was listed on the KYORIN Pharmaceutical Co. Ltd. balance sheet, income statement, cash flow, earnings &,... Data for torii Pharmaceutical Co., Ltd., a division of Donnelley financial Solutions Thursday, 5 November 2015.